ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o (Q56999804)
Jump to navigation
Jump to search
article by Simona Soverini et al published 20 June 2005 in Journal of Clinical Oncology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o |
article by Simona Soverini et al published 20 June 2005 in Journal of Clinical Oncology |
Statements
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o (English)
0 references
20 June 2005
0 references
23
0 references
18
0 references
4100-9
0 references